tysabri

Elan CEO: 'Very pleases' with initial Tysabri activity
MarketWatch - USA
... Corp. PLC's (ELN) chief executive said Tuesday he was "very pleased" with the initial activity for multiple sclerosis drug Tysabri. ...
See all stories on this topic

Elan cuts losses, pins hopes on Tysabri
Ireland Online - Dublin,Ireland
Elan is banking on MS drug Tysabri to return the company to the black, having launched it in recent weeks in Germany, Ireland, UK and Sweden and re-introduced ...

Elan Q2 losses narrow as Tysabri costs fall UPDATE
Hemscott - London,UK
LONDON (AFX) - Irish drug maker Elan Corp revealed narrowing second-quarter losses and said it is 'confident' the revenues from re-launched Tysabri will drive ...
See all stories on this topic

Elan Reports Second Quarter 2006 Financial Results
Genetic Engineering News (press release) - Larchmont,NY,USA
... business results. We recently received approval in the US and Europe to make Tysabri available to patients suffering from MS. We ...

Elan narrow Q2 losses
MoneyWeek (Subscription) - London,UK
... Elan reintroduced its multiple sclerosis treatment Tysabri after US Food and Drug Administration approval at the start of June. ...

Elan says pleased with Tysabri after relaunch
Reuters - USA
... Aug 1 (Reuters) - Irish drugmaker Elan (ELN.I: Quote, Profile, Research) said on Tuesday it was pleased with the performance of its Tysabri multiple sclerosis ...
See all stories on this topic